Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in fireside chats at the following investor conferences:
-
BofA Securities 2021 Health Care Conference
Date: Thursday, May 13th at 1:15 p.m. Eastern Time
-
2021 RBC Capital Markets Global Healthcare Conference
Date: Tuesday, May 18th at 9:45 a.m. Eastern Time
For presentations that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210503005585/en/
Sangamo Therapeutics Inc. Aktie
Die Community zeigt leichtes Desinteresse an Sangamo Therapeutics Inc. mit mehr Sell- als Buy-Einschätzungen.
Trotz eines Kursziels von 2 € für Sangamo Therapeutics Inc., das über 0.81 € liegt, zeigt sich ein Potenzial von 146.34%.
